DrugDashboards

Icotyde

icotrokinra · ICOTROKINRA 200 mg/1 · Tablet, Film Coated · Oral · Janssen Biotech, Inc.

NDC 57894-0201-07 · 1 BLISTER PACK in 1 CARTON / 7 TABLET, FILM COATED in 1 BLISTER PACK · NDA · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA220149
TE code
Approval date
Mar 17, 2026
Patents / exclusivity
3 patents, 1 exclusivities
TypeNumber / codeExpires
exclusivityNCEMar 17, 2031
patent11939361Nov 19, 2041
patent11845808Jan 14, 2041
patent12552836Jul 12, 2039

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of icotrokinra (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
Janssen Biotech, Inc.ICOTROKINRA 200 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Icotyde — NDC 57894-0201-07," retrieved September 3, 2026, https://drugdashboards.com/drug/57894020107.

Free to cite with attribution — see how the data is put together.